EQS-News: SCHOTT Pharma AG & Co. KGaA: SCHOTT Pharma with strong financial performance in fiscal year 2022
EQS-News: SCHOTT Pharma AG & Co. KGaA
- EQS-News: SCHOTT Pharma AG & Co. KGaA
SCHOTT Pharma AG & Co. KGaA: SCHOTT Pharma with strong financial performance in fiscal year 2022
The issuer is solely responsible for the content of this announcement. - In the fiscal year 20221, SCHOTT Pharma generated sales of EUR 821 million, marking a 27% increase compared to the previous year.
- Over the past five years, SCHOTT Pharma has realized sustained profitable topline growth of more than 10% CAGR.
- SCHOTT Pharma produced around 13 billion units for the pharma industry in the last fiscal year to safely store and administer medications.